Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-12

Clinical Trial Update: Risperidone for Treatment of Cocaine Dependence in Outpatients - 12 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating risperidone for treatment of cocaine use disorder in outpatients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Risperdal (risperidone)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Cocaine-Related Disorders | Phase 2 | Status: COMPLETED